The κ-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: An instance of 'pharmacologic congruence'

Brain Research

Volumn 1193, Issue , 2008, Pages 51-56

  Raffa, Robert B ^a   Stagliano, Gregory W ^a   Ross, Geoffrey ^a   Powell, Jenay A ^a   Phillips, Austin G ^a   Ding, Zhe ^a   Rawls, Scott M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Amphetamine; Cannabinoid; Cocaine; Physical dependence; Planarian; Withdrawal

Indexed keywords

AMPHETAMINE; CANNABINOID; CANNABINOID RECEPTOR AGONIST; COCAINE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE;

ARTICLE; COCAINE DEPENDENCE; DRUG DEPENDENCE; DRUG WITHDRAWAL; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

AMPHETAMINE; ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZOXAZINES; COCAINE; DISEASE MODELS, ANIMAL; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; MORPHOLINES; NALTREXONE; NAPHTHALENES; NARCOTIC ANTAGONISTS; PLANARIANS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

INVERTEBRATA; MAMMALIA; PLANARIA; TURBELLARIA;

EID: 39149088326     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.12.001     Document Type: Article

References (20)

1. Algeri S., Carolei A., Ferretti P., Gallone C., Palladini G., and Venturini G. Effects of dopaminergic agents on monoamine levels and motor behaviour in Planaria. Comp. Biochem. Physiol., Part C Pharmacol. Toxicol. 74 (1983) 27-29
2. Buttarelli F.R., Pontieri F.E., Margotta V., and Palladini G. Cannabinoid-induced stimulation of motor activity in planaria through an opioid receptor-mediated mechanism. Prog. Neuro-Psychopharmacol. Biol. Psytr. 26 (2002) 65-68
3. Carolei A., Margotta V., and Palladini G. Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations. Neuropsychobiology 1 (1975) 355-364
4. Compton D.R., Gold L.H., Ward S.J., Balster R.L., and Martin B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263 (1992) 1118-1126
5. Needleman H.L. Tolerance and dependence in the planarian after continuous exposure to morphine. Nature 215 (1967) 784-785
6. Palladini G., Ruggieri S., Stocchi F., De Pandis M.F., Venturini G., and Margotta V. A pharmacological study of cocaine activity in planaria. Comp. Biochem. Physiol., Part C Pharmacol. Toxicol. 115 (1996) 41-45
7. Passarelli F., Mercante A., Pontieri F.E., Margotta V., Venturini G., and Palladini G. Opioid-dopamine interaction in planaria: a behavioral study. Comp. Biochem. Physiol., Part C Pharmacol. Toxicol. 124 (1999) 51-55
8. Raffa R.B., and Valdez J.M. Cocaine withdrawal in Planaria. Eur. J. Pharmacol. 430 (2001) 143-145
9. Raffa R.B., and Desai P. Description and quantification of cocaine withdrawal signs in Planaria. Brain Res. 1032 (2005) 200-202
10. Raffa R.B., Holland L.J., and Schulingkamp R.J. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. Pharmacol. Toxicol. Methods 45 (2001) 223-226
11. Raffa R.B., Stagliano G.W., and Umeda S. κ-Opioid withdrawal in Planaria. Neurosci. Lett. 349 (2003) 139-142
12. Raffa R.B., Stagliano G.W., and Tallarida R.J. Subadditive withdrawal from cocaine/κ-opioid agonist combinations in Planaria. Brain Res. 1114 (2006) 31-35
13. Raffa R.B., Stagliano G.W., and Tallarida R.J. Nonlinear isobologram and super-additive withdrawal from cocaine:cannabinoid combinations in planarians. Eur. J. Pharmacol. 556 (2007) 89-90
14. Rawls S.M., Cabassa J., Geller E.B., and Adler M.W. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. J. Pharmacol. Exp. Ther. 301 (2002) 963-968
15. Rawls S.M., Rodriguez T., Baron D.A., and Raffa R.B. A nitric oxide synthase inhibitor μl-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Res. 1099 (2006) 82-87
16. Rawls S.M., Gomez T., and Raffa R.B. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 52212-2). Pharmacol. Biochem. Behav. 86 (2007) 499-504
17. Umeda S., Stagliano G.W., and Raffa R.B. Cocaine and κ-opioid withdrawal in Planaria blocked by d-, but not l-, glucose. Brain Res. 1018 (2004) 181-185
18. Venturini G., Carolei A., Palladini G., Margotta V., and Lauro M.G. Radioimmunological and immunocytochemical demonstration of Met-enkephalin in planaria. Comp. Biochem. Physiol., Part C Pharmacol. Toxicol. 74 (1983) 23-25
19. Venturini G., Stocchi F., Margotta V., Ruggieri S., Bravi D., Bellantuono P., and Palladini G. A pharmacological study of dopaminergic receptor in planaria. Neuropharmacology 28 (1989) 1377-1382
20. Welsh J.H., and Williams L.D. Monoamine containing neurons in Planaria. J. Comp. Neurol. 138 (1970) 103-116